All In Biotech

Drug Trial Radar · NCT04919512

A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

A Phase 2, Open-Label, Multi-Center, Randomized Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Scheduled for Radical Cystectomy and Are Ineligible for or Refusing Platinum-Based Neoadjuvant Chemotherapy

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 163 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

163

Actual

Start

Jul 7, 2022

Primary completion

Feb 4, 2025

Study completion Mar 31, 2026

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Jun 9, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the anti-tumor effects of TAR-200 in combination with intravenous (IV) cetrelimab and IV cetrelimab alone.

Conditions

  • Urinary Bladder Neoplasms

Interventions

  • TAR-200Drug

    TAR-200 will be administered.

  • CetrelimabBiological

    Cetrelimab will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pathologic Complete Response (pCR) RateTime frame: At Week 12

Locations

109 sites in 10 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Urological Associates of Southern Arizona, P.C.

    Tucson, Arizona

  • UAMS Winthrop P. Rockefeller Cancer Institute

    Little Rock, Arkansas

  • Arkansas Urology

    Little Rock, Arkansas

  • City of Hope

    Duarte, California

  • Genesis Research

    San Diego, California

  • Colorodo Urology- St. Anthony Hospital

    Golden, Colorado

  • University of Florida Health Jacksonville

    Jacksonville, Florida

  • Mayo Clinic

    Jacksonville, Florida

  • Baptist Hospital of Miami

    Miami, Florida

  • Winship Cancer Institute Emory University

    Atlanta, Georgia

  • Mount Sinai Queens Infusion Center

    Astoria, Illinois

  • DuPage Medical Group

    Lisle, Illinois

  • Urology of Indiana

    Indianapolis, Indiana

  • First Urology

    Jeffersonville, Indiana

  • University of Louisville - James Graham Brown Cancer Center

    Louisville, Kentucky

  • University Of Maryland Medical Center

    Baltimore, Maryland

  • Penn Medicine - PerelmanCenter for Advanced Medicine

    Baltimore, Maryland

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Michigan Institute of Urology, PC

    Troy, Michigan

  • University Of Minnesota

    Minneapolis, Minnesota

  • Mayo Clinic 1

    Rochester, Minnesota

  • Ellis Fischel Cancer Center

    Columbia, Missouri

  • Washington University School Of Medicine - Center For Advanced Medicine (CAM)

    St Louis, Missouri

  • David C. Pratt Cancer Center

    St Louis, Missouri

  • Robert Wood Johnson University Hospital

    New Brunswick, New Jersey

  • New York University Langone Medical Center

    New York, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • Associated Medical Professionals

    Syracuse, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center

    Winston-Salem, North Carolina

  • The Ohio State University

    Columbus, Ohio

  • MidLantic Urology

    Bala-Cynwyd, Pennsylvania

  • University Of Pittsburgh Medical Center UPMC Hillman Cancer Center

    Pittsburgh, Pennsylvania

  • Carolina Urologic Research Center

    Myrtle Beach, South Carolina

  • Urology Associates

    Nashville, Tennessee

  • Houston Metro Urology

    Houston, Texas

  • Urology San Antonio Research

    San Antonio, Texas

  • Huntsman Cancer Institute

    Salt Lake City, Utah

Showing 40 of 109 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.